Glyparamide

CAS No. 5581-42-0

Glyparamide( —— )

Catalog No. M33220 CAS No. 5581-42-0

Glyparamide is a hypoglycemic compound that reduces platelet aggregation, resulting in less atherosclerotic plaque formation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Glyparamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Glyparamide is a hypoglycemic compound that reduces platelet aggregation, resulting in less atherosclerotic plaque formation.
  • Description
    Glyparamide is an orally active chlorophenyl-containing sulfonylurea. Glyparamide shows hypoglycemic activity and rarely causes hepatic injury.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5581-42-0
  • Formula Weight
    353.82
  • Molecular Formula
    C15H16ClN3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 55 mg/mL (155.45 mM; Ultrasonic )
  • SMILES
    O=C(NC1=CC=C(C=C1)N(C)C)NS(=O)(=O)C2=CC=C(Cl)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yuntao Liu, et al. Emerging Theranostic Nanomaterials in Diabetes and Its Complications. Adv Sci (Weinh). 2022 Jan;9(3):e2102466.?
molnova catalog
related products
  • Raffinose(b)

    Raffinose is a natural compound.

  • Aminomalonic acid

    Aminomalonic acid (Ama) was first detected in alkaline hydrolysates of proteins in 1984. Ama has been isolated from proteins of Escherichia coli and human atherosclerotic plaque. The presence of Ama has important biological implications because the malonic acid moiety potentially imparts calcium binding properties to protein.

  • D-Fructose-16-diphos...

    Fosfructose trisodium is a cytoprotective natural sugar phosphate for the potential treatment of sickle cell anemia cardiovascular ischemia and asthma. It acts by stimulating anaerobic glycolysis which generates adenosine triphosphate under ischemic conditions.